Jingchong Liu
Overview
Explore the profile of Jingchong Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yi K, Liu J, Rong Y, Wang C, Tang X, Zhang X, et al.
Front Mol Biosci
. 2021 Dec;
8:631152.
PMID: 34869576
Every year, nearly 170,000 people die from bladder cancer worldwide. A major problem after transurethral resection of bladder tumor is that 40-80% of the tumors recur. Ferroptosis is a type...
12.
Wang Q, Xu J, Xiong Z, Xu T, Liu J, Liu Y, et al.
J Transl Med
. 2021 Oct;
19(1):417.
PMID: 34627268
Clear cell renal cell carcinoma (ccRCC) is the most common malignant tumor of the kidney. New and reliable biomarkers are in urgent need for ccRCC diagnosis and prognosis. The CENP...
13.
Li D, Li H, Zheng S, Gao N, Li S, Liu J, et al.
J Colloid Interface Sci
. 2021 Sep;
607(Pt 1):655-661.
PMID: 34530186
Owing to the low cost, high energy density, and high theoretical specific capacity, lithium-sulfur batteries have been deemed as a potential choice for future energy storage devices. However, they also...
14.
Gao S, Ruan H, Liu J, Liu Y, Liu D, Tong J, et al.
Front Oncol
. 2021 Aug;
11:678694.
PMID: 34367965
Ferroptosis is a novel form of cell death and plays a role in various diseases, especially tumors. It has been reported that ferroptosis is involved in the growth and progression...
15.
Xu J, Liu Y, Liu J, Shou Y, Xiong Z, Xiong H, et al.
Front Oncol
. 2021 Jul;
11:659208.
PMID: 34249694
Clear cell renal cell carcinoma (ccRCC) accounts for approximately 4/5 of all kidney cancers. Accumulation of minor changes in the cellular homeostasis may be one cause of ccRCC. Therefore, we...
16.
Xu T, Gao S, Ruan H, Liu J, Liu Y, Liu D, et al.
Front Genet
. 2021 Jun;
12:609174.
PMID: 34122497
Clear cell renal cell carcinoma (ccRCC) is characterized by its insensitivity to chemoradiotherapy and lacks effective diagnostic and prognostic biomarkers. In this study, we focused on the role of m6A...
17.
MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma
Xu T, Gao S, Liu J, Huang Y, Chen K, Zhang X
J Cancer
. 2021 Mar;
12(8):2243-2257.
PMID: 33758602
Immunotherapy is a novel approach and has been used in various diseases, especially in cancers. Recently, immunotherapy has gradually been used to treat advanced clear cell renal cell carcinoma (ccRCC)...
18.
Xu J, Liu Y, Liu J, Xu T, Cheng G, Shou Y, et al.
Front Genet
. 2020 Dec;
11:602485.
PMID: 33343639
RNA methylation accounts for over 60% of all RNA modifications, and N-methyladenosine (mA) is the most common modification on mRNA and lncRNA of human beings. It has been found that...
19.
Li D, Guo F, Cui Z, Zhou J, Zhai Y, Du Y, et al.
ACS Appl Mater Interfaces
. 2020 Nov;
12(47):53503-53509.
PMID: 33169964
The rapid response movement caused by the Marangoni effect, a surface tension gradient-induced mass transfer behavior, has spurred considerable promise for diverse applications from microrobots and microreactors to smart drug...
20.
Cheng G, Liu Y, Liu L, Ruan H, Cao Q, Song Z, et al.
Aging (Albany NY)
. 2020 Sep;
12(17):17459-17479.
PMID: 32921632
Patients with advanced renal cell carcinoma who are resistant to sunitinib currently have limited clinical options for treatment. Therefore, it is necessary to explore the biological basis of sunitinib resistance...